Search Results - "Taylor-Harding B"

Molecular and spatial differences in the tumor microenvironment of high-grade serous ovarian cancers with short versus long-term survival.

Authors: Smick AH Zurek N Taylor-Harding B et al.

Source: Gynecologic oncology [Gynecol Oncol] 2026 Jul; Vol. 210, pp. 55-62. Date of Electronic Publication: 2026 May 23.

Publication Type: Journal Article

Journal Info: Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-6859 (Electronic) Linking ISSN: 00908258 NLM ISO Abbreviation: Gynecol Oncol Subsets: MEDLINE

Differential Preclinical Efficacy of Combined CDK4/6 and MEK Inhibition in Low-Grade Serous Ovarian Carcinoma Based on KRAS/NF1 Mutational Status.

Authors: Bittner, Madison Llaurado Fernandez, Marta Hoenisch, Joshua et al.

Source: International Journal of Molecular Sciences. Feb2026, Vol. 27 Issue 4, p1774. 24p.

Integrative Single-Cell and Machine Learning Analysis Develops a Glutamine Metabolism–Based Prognostic Model and Identifies MSMO1 as a Therapeutic Target in Osteosarcoma.

Authors: Ma, Hui Zhang, Haiyang Bajgai, Johny et al.

Source: Biomolecules (2218-273X). Dec2025, Vol. 15 Issue 12, p1664. 25p.

The VALTIVE1 study protocol: a study for the validation of Tie2 as the first tumour vascular response biomarker for VEGF inhibitors.

Authors: Carucci, Margherita Clamp, Andrew Zhou, Cong et al.

Source: BMC Cancer. 10/24/2024, Vol. 24 Issue 1, p1-10. 10p.

TPD52 promotes the proliferation and metastasis of gastric cancer cells.

Authors: Zhang, Shunhao Geng, Zhixin Sun, Jian et al.

Source: BMC Gastroenterology. 10/3/2025, Vol. 25 Issue 1, p1-16. 16p.

Activin A Secreted by Cancer-Associated Fibroblasts Reduces the Sensitivity of Breast Cancer Cells to Ixazomib via Inhibition of Proteasome Activity.

Authors: Geng, Shuaiming Liu, Siyao Liu, He et al.

Source: Biomolecules (2218-273X). Sep2025, Vol. 15 Issue 9, p1318. 19p.

Genomic Predictors of Platinum Resistance and Survival in High-Grade Serous Ovarian Carcinoma: Insights from an Explorative Targeted Next-Generation Sequencing Analysis.

Authors: De Marco, Carmela Rocca, Valentina Migliozzi, Simona et al.

Source: Cancers. May2026, Vol. 18 Issue 9, p1390. 24p.

INHBA⁺ macrophages and Pro-inflammatory CAFs are associated with distinctive immunosuppressive tumor microenvironment in submucous Fibrosis-Derived oral squamous cell carcinoma.

Authors: Zhao, Simin Zhang, Yu Meng, Xiaoqin et al.

Source: BMC Cancer. 5/12/2025, Vol. 25 Issue 1, p1-19. 19p.

Transitional CXCL14⁺ cancer‐associated fibroblasts enhance tumour metastasis and confer resistance to EGFR‐TKIs, revealing therapeutic vulnerability to filgotinib in lung adenocarcinoma.

Authors: Xu, Weijiao Yang, Haitang Xu, Ke et al.

Source: Clinical & Translational Medicine. Apr2025, Vol. 15 Issue 4, p1-25. 25p.

Nicotinamide N-methyltransferase as a therapeutic target in taxane-resistant castration-resistant prostate cancer.

Authors: Cevatemre B Karyemez E Bulut I et al.

Source: Cell death discovery [Cell Death Discov] 2026 Apr 17; Vol. 12 (1). Date of Electronic Publication: 2026 Apr 17.

Publication Type: Journal Article

Journal Info: Publisher: Nature Publishing Group Country of Publication: United States NLM ID: 101665035 Publication Model: Electronic Cited Medium: Print ISSN: 2058-7716 (Print) Linking ISSN: 20587716 NLM ISO Abbreviation: Cell Death Discov Subsets: PubMed not MEDLINE

Fueling the Seed: Growth Factors and Cytokines Driving Cancer Stem Cells in Gynecological Malignancies.

Authors: Sarcinella, Alessandro Guerra Villacis, Juan Sebastian Brizzi, Maria Felice

Source: International Journal of Molecular Sciences. Dec2025, Vol. 26 Issue 23, p11462. 33p.

OVsignGenes: A Gene Expression-Based Neural Network Model Estimated Molecular Subtype of High-Grade Serous Ovarian Carcinoma.

Authors: Kobelyatskaya, Anastasiya Tregubova, Anna Palicelli, Andrea et al.

Source: Cancers. Dec2024, Vol. 16 Issue 23, p3951. 12p.

This result is not displayed to guests.
Login for full access.

A phase 1 trial of fuzuloparib in combination with apatinib for advanced ovarian and triple-negative breast cancer: efficacy, safety, pharmacokinetics and germline BRCA mutation analysis.

Authors: Liu, Yaxin Wang, Wei Yin, Rutie et al.

Source: BMC Medicine. 9/29/2023, Vol. 21 Issue 1, p1-10. 10p.

基于类器官构建泛TKI提高ET+CDK4/6抑制剂 治疗HR+ /HER2-low乳腺癌疗效的筛选工具.

Alternate Title: Development of an organoid⁃based pan-TKI precision screening platform to enhance therapeutic efficacy of ET+CDK4/6 inhibitors in HR+ /HER2 ⁃ low breast cancer.

Authors: 吴迎朝 陈柳汕 梁裕琪 et al.

Source: Journal of Practical Medicine / Shiyong Yixue Zazhi. 9/25/2025, Vol. 41 Issue 18, p2786-2795. 10p.

Cancer Growth and Invasion Are Increased in the Tight Skin (TSK) Mouse.

Authors: Recouvreux, Maria Sol Taylor-Harding, Barbie Rowat, Amy C. et al.

Source: Cancers. Sep2025, Vol. 17 Issue 18, p2943. 19p.

Reclassify High-Grade Serous Ovarian Cancer Patients Into Different Molecular Subtypes With Discrepancy Prognoses and Therapeutic Responses Based on Cancer-Associated Fibroblast-Enriched Prognostic Genes.

Authors: Liu, Xiangxiang Ping, Guoqiang Ji, Dongze et al.

Source: Biomedical Engineering & Computational Biology. 8/30/2024, p1-13. 13p.

Homologous Recombination Deficiency and Cyclin E1 Amplification Are Correlated with Immune Cell Infiltration and Survival in High-Grade Serous Ovarian Cancer.

Authors: van Wagensveld, Lilian van Baal, Juliette O. A. M. Timmermans, Maite et al.

Source: Cancers. Dec2022, Vol. 14 Issue 23, p5965. 17p.

Aurantio-obtusin modulates Wilms Tumour 1 within the breast tumour microenvironment reducing immunosuppression and tumour growth.

Authors: Li, Rui O'Connor, Dómhnall J Digby, Barry et al.

Source: Cell Communication & Signaling. 7/1/2025, Vol. 23 Issue 1, p1-23. 23p.

Pre-operative levels of angiopoietin protein-like 3 (ANGPTL3) in women diagnosed with high-grade serous carcinoma of the ovary.

Authors: Wong Chong, Emilie Joncas, France-Hélène Douville, Pierre et al.

Source: Lipids in Health & Disease. 2/27/2024, Vol. 23 Issue 1, p1-10. 10p.